ICGN » Topics » Common Stock Reserved for Future Issuance

This excerpt taken from the ICGN 10-K filed Mar 16, 2009.

Common Stock Reserved for Future Issuance

The Company had reserved shares of common stock for future issuance as follows:

 

     December 31,
2008

Outstanding stock options

   5,683,558

Outstanding restricted stock units

   559,948

Outstanding warrants

   5,218,920

Possible future issuance under the 2004 equity compensation plan

   2,887,234
    

Total shares reserved

   14,349,660
    
These excerpts taken from the ICGN 10-K filed Mar 7, 2008.

Common Stock Reserved for Future Issuance

The Company had reserved shares of common stock for future issuance as follows:

 

     December 31,
2007

Outstanding stock options

   5,069,303

Outstanding restricted stock units

   413,964

Outstanding warrants

   5,218,920

Possible future issuance under the 2004 equity compensation plan

   2,861,034
    

Total shares reserved

   13,563,221
    

Common Stock Reserved for
Future Issuance

The Company had reserved shares of common stock for future issuance as follows:

STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"> 








































   December 31,
2007

Outstanding stock options

  5,069,303

Outstanding restricted stock units

  413,964

Outstanding warrants

  5,218,920

Possible future issuance under the 2004 equity compensation plan

  2,861,034
   

Total shares reserved

  13,563,221
   
This excerpt taken from the ICGN 10-K filed Mar 6, 2007.

Common Stock Reserved for Future Issuance

 

The Company had reserved shares of common stock for future issuance as follows:

 

     December 31,
2006

Outstanding stock options

   4,867,335

Outstanding restricted stock units

   192,932

Possible future issuance under the 2004 equity compensation plan

   834,023
    

Total shares reserved

   5,894,290
    

 

99


Table of Contents

Icagen, Inc.

 

Notes to Financial Statements—(Continued)

 

This excerpt taken from the ICGN 10-K filed Mar 15, 2006.

Common Stock Reserved for Future Issuance

 

The Company had reserved shares of common stock for future issuance as follows:

 

     December 31,
2005


   December 31,
2004


For conversion of Preferred Stock:

         

Series A

   —      325,000

Series B

   —      1,229,540

Series C

   —      1,521,442

Series D

   —      2,065,049

Series E

   —      1,221,825

Series E-1

   —      455,235

Series F

   —      3,581,612

Series G

   —      201,046

Series G-1

   —      1,778,143

Series H

   —      2,441,171

Outstanding warrants

   —      26,307

Outstanding stock options

   3,680,775    3,502,207

Outstanding restricted stock units

   37,407    —  

Possible future issuance under the 2004 equity compensation plan

   2,496,883    —  

Possible future issuance under the 1996 equity compensation plan

   —      614,549
    
  

Total shares reserved

   6,215,065    18,963,126
    
  

 

This excerpt taken from the ICGN 10-K filed Mar 31, 2005.

Common Stock Reserved for Future Issuance

 

The Company had reserved shares of common stock for future issuance as follows:

 

     December 31,
2004


   December 31,
2003


For conversion of Preferred Stock:

         

Series A

   325,000    325,000

Series B

   1,229,540    1,136,207

Series C

   1,521,442    1,521,740

Series D

   2,065,049    2,075,849

Series E

   1,221,825    1,221,825

Series E-1

   455,235    455,235

Series F

   3,581,612    3,581,612

Series G

   201,046    201,046

Series G-1

   1,778,143    1,778,143

Series H

   2,441,171    2,441,171

Outstanding warrants

   26,307    119,640

Outstanding stock options

   3,502,207    2,852,158

Possible future issuance under the 1996 equity compensation plan

   614,549    585,591
    
  

Total shares reserved

   18,963,126    18,295,217
    
  

 

101


Table of Contents

Icagen, Inc.

 

Notes to Financial Statements—(Continued)

 

RELATED TOPICS for ICGN:

"Common Stock Reserved for Future Issuance" elsewhere:

NeuroMetrix (NURO)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki